全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Expression of TPM1, a Novel Sarcomeric Isoform of the TPM1 Gene, in Mouse Heart and Skeletal Muscle

DOI: 10.1155/2014/896068

Full-Text   Cite this paper   Add to My Lib

Abstract:

We have investigated the expression of TPM1α and TPM1κ in mouse striated muscles. TPM1α and TMP1κ were amplified from the cDNA of mouse heart by using conventional RT-PCR. We have cloned the PCR amplified DNA and determined the nucleotide sequences. Deduced amino acid sequences show that there are three amino acid changes in mouse exon 2a when compared with the human TPM1κ. However, the deduced amino acid sequences of human TPM1α and mouse TPM1α are identical. Conventional RT-PCR data as well as qRT-PCR data, calculating both absolute copy number and relative expression, revealed that the expression of TPM1κ is significantly lower compared to TPM1α in both mouse heart and skeletal muscle. It was also found that the expression level of TPM1κ transcripts in mouse heart is higher than it is in skeletal muscle. To the best of our knowledge, this is the first report of the expression of TPM1κ in mammalian skeletal muscle. 1. Introduction Tropomyosins (TMs) are a family of highly conserved actin binding proteins which are expressed in all eukaryotes from yeast to humans. TMs play a critical role in the control of Ca+2-regulated thin filament function in striated muscle contraction. Except for zebrafish, in vertebrates, there are four known tropomyosin (TPM) genes (designated as TPM1, TPM2, TPM3, and TPM4) [1–6]. In zebrafish, six tropomyosin genes have been reported [7]. Each of the TPM genes generates a multitude of tissue and developmental specific isoforms via alternate splicing. TPM1 is known to produce at least ten alternatively spliced transcript variants [8]. In mammals, the predominant striated muscle isoform is TPM1α containing exons 1a, 2b, 3, 4, 5, 6b, 7, 8, and 9a/b, which encode 284 amino acid residues. Our laboratory first reported another striated muscle isoform known as TPM1κ in axolotl heart [9] that contains exons 1a, 2a (instead of exon 2b), 3, 4, 5, 6b, 7, 8, and 9a/b. We also reported the expression of TPM1κ in axolotl skeletal muscle [8], human heart [10], and embryonic chicken heart [11]. In humans, TPM1κ is expressed in both fetal and adult hearts, whereas in chicken both TPM1α and TPM1κ are expressed only in embryonic heart [11]. Interestingly, transgenic mice that overexpressed human TPM1κ, in a cardiac-specific manner, were found to develop a dilated cardiomyopathy-like syndrome [12]. However, it was not clear whether TPM1κ is expressed in normal mouse hearts. Two possible reasons for observing some abnormalities in TG mouse hearts ectopically overexpressing human TPM1κ were that too much TPM1κ is toxic to the mouse cardiomyocyte or

References

[1]  P. Gunning, G. O'Neill, and E. Hardeman, “Tropomyosin-based regulation of the actin cytoskeleton in time and space,” Physiological Reviews, vol. 88, no. 1, pp. 1–35, 2008.
[2]  J. P. Lees-Miller and D. M. Helfman, “The molecular basis for tropomyosin isoform diversity,” BioEssays, vol. 13, no. 9, pp. 429–437, 1991.
[3]  S. V. Perry, “Vertebrate tropomyosin: distribution, properties and function,” Journal of Muscle Research and Cell Motility, vol. 22, no. 1, pp. 5–49, 2001.
[4]  K. Pieples and D. F. Wieczorek, “Tropomyosin 3 increases striated muscle isoform diversity,” Biochemistry, vol. 39, no. 28, pp. 8291–8297, 2000.
[5]  M. F. Pittenger, J. A. Kazzaz, and D. M. Helfman, “Functional properties of non-muscle tropomyosin isoforms,” Current Opinion in Cell Biology, vol. 6, no. 1, pp. 96–104, 1994.
[6]  D. F. Wieczorek, “Regulation of alternatively spliced α-tropomyosin gene expression by nerve extract,” Journal of Biological Chemistry, vol. 263, no. 21, pp. 10456–10463, 1988.
[7]  G. Schevzov, S. P. Whittaker, T. Fath, J. J. Lin, and P. W. Gunning, “Tropomyosin isoforms and reagents,” Bioarchitecture, vol. 1, pp. 135–164, 2011.
[8]  A. Thomas, S. Rajan, H. L. Thurston et al., “Expression of a novel tropomyosin isoform in axolotl heart and skeletal muscle,” Journal of Cellular Biochemistry, vol. 110, no. 4, pp. 875–881, 2010.
[9]  E. A. Luque, B. J. Spinner, S. Dube, D. K. Dube, and L. F. Lemanski, “Differential expression of a novel isoform of α-tropomyosin in cardiac and skeletal muscle of the Mexican axolotl (Ambystoma mexicanum),” Gene, vol. 185, no. 2, pp. 175–180, 1997.
[10]  C. R. Denz, A. Narshi, R. W. Zajdel, and D. K. Dube, “Expression of a novel cardiac-specific tropomyosin isoform in humans,” Biochemical and Biophysical Research Communications, vol. 320, no. 4, pp. 1291–1297, 2004.
[11]  R. W. Zajdel, C. R. Denz, S. Lee et al., “Identification, characterization, and expression of a novel α-tropomyosin isoform in cardiac tissues in developing chicken,” Journal of Cellular Biochemistry, vol. 89, no. 3, pp. 427–439, 2003.
[12]  S. Rajan, G. Jagatheesan, C. N. Karam et al., “Molecular and functional characterization of a novel cardiac-specific human tropomyosin isoform,” Circulation, vol. 121, no. 3, pp. 410–418, 2010.
[13]  C. R. Denz, C. Zhang, P. Jia et al., “Absence of mutation at the 50-upstream promoter region of the TPM4 gene from cardiac mutant axolotl (Ambystoma mexicanum),” Cardiovascular Toxicology, vol. 11, no. 3, pp. 235–243, 2011.
[14]  H. L. Thurston, S. Prayaga, A. Thomas et al., “Expression of Nkx2.5 in wild type, cardiac mutant, and thyroxine-induced metamorphosed hearts of the mexican axolotl,” Cardiovascular Toxicology, vol. 9, no. 1, pp. 13–20, 2009.
[15]  M. W. Pffaffl, “A new mathematical model for relative quantification in real-time RT-PCR,” Nucleic Acids Research, vol. 29, pp. 2002–2007, 2001.
[16]  K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method,” Methods, vol. 25, no. 4, pp. 402–408, 2001.
[17]  R. W. Zajdel, C. R. Denz, A. Narshi, S. Dube, and D. K. Dube, “Anti-sense-mediated inhibition of expression of the novel striated tropomyosin isoform TPM1κ disrupts myofibril organization in embryonic axolotl hearts,” Journal of Cellular Biochemistry, vol. 95, no. 4, pp. 840–848, 2005.
[18]  J. Wang, J. M. Sanger, S. Kang et al., “Ectopic expression and dynamics of TPM1α and TPM1κ in myofibrils of avian myotubes,” Cell Motility and the Cytoskeleton, vol. 64, no. 10, pp. 767–776, 2007.
[19]  D. Wernicke, C. Thiel, C. M. Duja-Isac et al., “α-tropomyosin mutations Asp175 Asn and Glu180 Gly affect cardiac function in transgenic rats in different ways,” American Journal of Physiology: Regulatory Integrative and Comparative Physiology, vol. 287, no. 3, pp. R685–R695, 2004.
[20]  C. N. Karam, C. M. Warren, S. Rajan, P. P. de Tombe, D. F. Wieczorek, and R. J. Solaro, “Expression of tropomyosin-κ induces dilated cardiomyopathy and depresses cardiac myofilament tension by mechanisms involving cross-bridge dependent activation and altered tropomyosin phosphorylation,” Journal of Muscle Research and Cell Motility, vol. 31, no. 5-6, pp. 315–322, 2011.
[21]  T. M. Olson, N. Y. Kishimoto, F. G. Whitby, and V. V. Michels, “Mutations that alter the surface charge of alpha-tropomyosin are associated with dilated cardiomyopathy,” Journal of Molecular and Cellular Cardiology, vol. 33, no. 4, pp. 723–732, 2001.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133